Izana Bioscience: Initiation of two-centre compassionate use study involving namilumab in the treatment of individual patients with rapidly worsening COVID-19 infection in Italy
April 06, 2020 07:00 ET
|
Izana Bioscience
Initiation of two-centre compassionate use study involving namilumab in the treatment of individual patients with rapidly worsening COVID-19 infection in Italy Emergency access granted to...
Izana Bioscience: Initiation of two-centre compassionate use study involving namilumab in the treatment of individual patients with rapidly worsening COVID-19 infection in Italy
April 06, 2020 02:00 ET
|
Izana Bioscience
Initiation of two-centre compassionate use study involving namilumab in the treatment of individual patients with rapidly worsening COVID-19 infection in Italy Emergency access granted to...